AGP Executive Report
Last update: 7 hours agoMedicare Advantage Deadline Shock: A new wave of plain “countdown” notices is hitting members nationwide: if a plan is ending in 2027, insurers must mail a nonrenewal notice by Oct 2, 2026, and missing it can trap people in the wrong coverage choice. Medicare Fraud Crackdown: The DOJ says Medicare “explanation of benefits” listed doctors patients never saw and durable medical equipment they never received, tied to a $1.3B fraud case. FDA Action on Counterfeit Drugs: The FDA charged three people for selling banned and bogus medicines. Global Detention Alarm (Yemen): A detained UN staffer with Crohn’s disease and other serious complications is reportedly denied specialist care, raising urgent rights-to-health concerns. Drug Shortages: The U.S. now lists 227 shortages, with the FDA adding 12 more. Pharmacy Access & Safety: Food City says flu shots are back at participating pharmacies; Iraq’s parliament forms a committee to curb medicine price exploitation and push clearer prescriptions. Clinical Updates: A phase 4 study reports valbenazine improved quality of life and daily functioning in tardive dyskinesia; real-world data suggests LEMS tied to SCLC may be underdiagnosed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
